Fu LW - Search Results

1

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro.

Yan YY, Wang F, Zhao XQ, Wang XK, Chen YF, Liu H, Xie Y, Fu LW. Yan YY, et al. Among authors: fu lw. Oncol Rep. 2017 Jan;37(1):31-40. doi: 10.3892/or.2016.5230. Epub 2016 Nov 8. Oncol Rep. 2017. PMID: 27840996 Free PMC article.

2

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.

Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q. Fu L, et al. Cancer Chemother Pharmacol. 2004 Apr;53(4):349-56. doi: 10.1007/s00280-003-0742-5. Epub 2003 Dec 10. Cancer Chemother Pharmacol. 2004. PMID: 14666379

3

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW. Chen LM, et al. Among authors: fu lw. J Pharm Pharmacol. 2004 Aug;56(8):1061-6. doi: 10.1211/0022357043879. J Pharm Pharmacol. 2004. PMID: 15285852

4

Screening novel, potent multidrug-resistant modulators from imidazole derivatives.

Chen LM, Wu XP, Ruan JW, Liang YJ, Ding Y, Shi Z, Wang XW, Gu LQ, Fu LW. Chen LM, et al. Among authors: fu lw. Oncol Res. 2004;14(7-8):355-62. doi: 10.3727/0965040041292378. Oncol Res. 2004. PMID: 15301426

5

[Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].

Chen LM, Li YF, Zhang X, Yan SL, Liang YJ, Fu LW. Chen LM, et al. Among authors: fu lw. Ai Zheng. 2005 Feb;24(2):189-93. Ai Zheng. 2005. PMID: 15694031 Chinese.

6

P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.

Wu QL, Wu XP, Liang YJ, Chen LM, Ding Y, Fu LW. Wu QL, et al. Among authors: fu lw. World J Gastroenterol. 2005 Jun 21;11(23):3544-8. doi: 10.3748/wjg.v11.i23.3544. World J Gastroenterol. 2005. PMID: 15962371 Free PMC article.

7

Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.

Shi Z, Liang YJ, Chen ZS, Wang XW, Wang XH, Ding Y, Chen LM, Yang XP, Fu LW. Shi Z, et al. Among authors: fu lw. Cancer Biol Ther. 2006 Jan;5(1):39-47. doi: 10.4161/cbt.5.1.2236. Epub 2006 Jan 12. Cancer Biol Ther. 2006. PMID: 16319528 Free article.

8

Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice.

Dai CL, Xiong HY, Tang LF, Zhang X, Liang YJ, Zeng MS, Chen LM, Wang XH, Fu LW. Dai CL, et al. Among authors: fu lw. Cancer Chemother Pharmacol. 2007 Oct;60(5):741-50. doi: 10.1007/s00280-007-0420-0. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273824

9

Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.

Shi Z, Liang YJ, Chen ZS, Wang XH, Ding Y, Chen LM, Fu LW. Shi Z, et al. Among authors: fu lw. Oncol Rep. 2007 Apr;17(4):969-76. Oncol Rep. 2007. PMID: 17342344

10

FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo.

Deng WJ, Yang XQ, Liang YJ, Chen LM, Yan YY, Shuai XT, Fu LW. Deng WJ, et al. Among authors: fu lw. Acta Pharmacol Sin. 2007 Jun;28(6):913-20. doi: 10.1111/j.1745-7254.2007.00565.x. Acta Pharmacol Sin. 2007. PMID: 17506952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters